Lower Urinary Tract Symptoms (LUTS)
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Bright UroGlean Urodynamics System
Bright UroGlean Urodynamics System
AstellasVesitirim™
Clinical Trials (3)
Total enrollment: 584 patients across 3 trials
The Glean Registry
Start: Apr 2026Est. completion: May 2027500 patients
N/AActive Not Recruiting
Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults
Start: Mar 2026Est. completion: Mar 202772 patients
N/ARecruiting
Vesitirim™ in Men Postmarketing Observational Study
Start: Feb 2012Est. completion: Dec 201212 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 584 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.